GlassScriptPhysician profile
Leigh Ann Jones
NPI 1437667037
$2,434.32
in general payments reported to CMS, 2019-2025
30 companies · $814 in 2025
The $814 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.70 · 2023: $799 · 2024: $765 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,377.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.34 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $250.33 | 2023-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $248.50 | 2022-2024 | Xarelto, Opsumit |
| Novartis Pharmaceuticals Corporation | $215.97 | 2023-2025 | |
| Esperion Therapeutics, INC. | $181.81 | 2023-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $174.56 | 2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.25 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $118.72 | 2024-2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $112.76 | 2025 | Onpattro |
| Amgen INC. | $91.33 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $66.04 | 2024-2025 | |
| Baxter Healthcare | $45.63 | 2024 | Biopharma Sol - Contract Manuf |
| Philips North America LLC | $44.23 | 2024 | (Ck7) Extended Holter |
| Novo Nordisk INC | $42.56 | 2025 | Wegovy, Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $39.97 | 2024 | Arcalyst |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $36.48 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $32.87 | 2025 | |
| Daiichi Sankyo INC. | $29.51 | 2023 | Injectafer |
| Recor Medical INC | $26.28 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biotronik INC. | $22.98 | 2024 | Biomonitor |
| Inspire Medical Systems, INC. | $21.77 | 2025 | Inspire |
| Heartflow, INC. | $20.49 | 2025 | |
| Arjo INC. | $19.78 | 2025 | |
| Medicomp INC | $19.47 | 2023 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals, LTD. | $19.45 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $19.39 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $18.29 | 2023 | Optimizer |
| Abbott Laboratories | $17.71 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Irhythm Technologies, INC. | $15.96 | 2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $13.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.